Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 26, 2008BMC CancerOpen Access

ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression

View Full Paper
Ask AI
Bookmark
Share

Authors

FFFlorian FritzscheKWKirsten WassermannMJMonika Jung

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Fritzsche et al. (2008) studied this question.

synapsesocial.com/papers/6a8a8da2f8670bac6e33808dhttps://doi.org/10.1186/1471-2407-8-179
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The disintegrin domain of ADAM9: a ligand for multiple β1 renal integrins2005 · 49 citations
  2. 2The expression of ADAM12 (meltrin α) in human giant cell tumours of bone2002 · 41 citations
  3. 3Meltrin γ (ADAM-9) mediates cellular adhesion through α6β1 integrin, leading to a marked induction of fibroblast cell motility2000 · 190 citations